Instructions for Protargol-LOR (silver proteinate) tablets for solution 200 mg
English Product Name
Protargol-LOR
Release Form
Tablets for preparation of solution for local application
Description Protargol-LOR
Tablets for the preparation of the solution for topical use from brown to dark brown or almost black color with a bluish hue, allowed irregularities in coloring, round, flat-cylindrical, beveled and risky.
1 tab
silver proteinate (protargol) 200 mg
Auxiliary substances: hydroxypropylmethylcellulose - 10 mg.
1 pc - end-of-line mesh packages (1) (complete with pipette cover and fl. 1 pc.) - packs of cardboard.
2 pcs. - end-of-line mesh packages (1) (complete with pipette cover and fl. 1 pc.) - packs of cardboard.
ATX codes
R01AX10 Other drugs
Active ingredient
silver proteinate
Pharmacotherapeutic group Protargol-LOR
Antiseptic agent
Pharmacological properties
The preparation, which is based on silver, is an effective agent with a high protein silver content (7.5-8.5%). It performs an action that manifests itself in the form of astringent, antiseptic and anti-inflammatory effects. In the context of topical application, protein silver dissociates to form silver ions, which bind to the bacteria's DNA and prevent them from multiplying on mucous membranes. The mechanism of action of protein silver consists in the deposition of silver ions on proteins, thereby creating a protective film on the damaged mucous membranes. This leads to narrowing of blood vessels and decreased sensitivity of nerve endings. The result is a reduction in edema and suppression of inflammatory reactions. Silver ions also have the ability to suppress the reproduction of various bacteria, including gram-positive and gram-negative microorganisms such as V. cereus, C. albicans, E. coli, R. aeruginosa, S. aureus, A. niger, S. Abony and others.
Testimony Protargol-LOR
Silver proteinate is recommended for symptomatic treatment of acute nasopharyngitis, sinusitis, and acute rhinitis.
Method of use, course and dosage Protargol-LOR
The drug is recommended to be applied topically three times a day, taking into account the individual scheme, depending on the age and form of release.
- Nosology (ICD codes)
- J00
- Acute nasopharyngitis (runny nose)
- J01
- Acute sinusitis
